热淋清联合左氧氟沙星治疗慢性细菌性前列腺炎的临床效果及治疗安全性评价

Abstract
Figure/Table
References (15)
Related Citation (6)

Download: PDF (0 KB) HTML (26 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo explore the clinical effect of Relinqing combined with Levofloxacin in thetreatment of chronic bacterial prostatitis and evaluate its therapeutic safety.MethodsFrom May 2015 to May 2017,100 patients diagnosed as chronic bacterial prostatitis treated in our hospital were selected as subjects.By a random number table mathod,they were evenly divided into research group and control group,50 cases in each group.The patients in the control group was treated with Levofloxacin,while the research group was treated wuth Relinqing combined with Levofloxacin.The treatment effect,the white blood cell index of the prostatic fluid(EPS-WBC),the prostate inflammation index(CPSI)and the incidence of adverse reactions of the two groups were compared.ResultsThe total effective rate of the patients in the study group(98.00%)was higher than that in the control group(78.00%),and the difference was statistically significant(P<0.05).After treatment,the EPS-WBS and CPSI of the study group were significantly lower than those in the control group,and the difference was statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).ConclusionCombination of Relinqing and Levofloxacin obtains a remarkable effect on treating chronic bacterial prostatitis by improving patients′clinical symptoms in few adverse reactions,which is worthy of clinical promotion.

Key words： Relinqing Levofloxacin Chronic bacterial prostatitis The total effective rate Adverse reaction

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Yi-de
	ZHANG Yong-ke
	LONG Qi
	SONG Shao-kang

Cite this article:

CHEN Yi-de,ZHANG Yong-ke,LONG Qi, et al. Evaluation of clinical effect and therapeuticsafety of Relinqing combined with Levofloxacin in the treatment of chronic bacterial prostatitis[J]. 中国当代医药, 2018, 25(5): 132-134.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I5/132

[1]	王顺军，陈韬，方克伟，等.双石通淋胶囊治疗慢性细菌性前列腺炎的临床疗效观察[J].昆明医科大学学报，2015，36（3）：91-94.
[2]	符贻翻，史南，沈仕兴.热淋清颗粒联合多沙唑嗪和左氧氟沙星治疗慢性细菌性前列腺炎的疗效观察[J].现代药物与临床，2016，31（10）：1632-1635.
[3]	Rees J，Abrahams M，Doble A，et al.Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome：a consensus guideline[J].Bju Int，2015，116（4）：509-525.
[4]	阿斯甫江·阿布都热依木，杨宏林，加尔肯·热合木，等.HPV、CMV与老年男性慢性前列腺炎的关系研究[J].国际病毒学杂志，2016，23（2）：108-111.
[5]	符贻翻，史南，沈仕兴.热淋清颗粒联合多沙唑嗪和左氧氟沙星治疗慢性细菌性前列腺炎的疗效观察[J].现代药物与临床，2016，31（10）：1632-1635.
[6]	Bowen DK，Dielubanza E，Schaeffer AJ.Chronic bacterial prostatitis and chronic pelvic pain syndrome[J].Bmj Clinical Evidence，2015，8（27）：2015.
[7]	孙治林，许莉莉，李军贵，等.还春通淋胶囊治疗慢性非细菌性前列腺炎 87例疗效观察[J].西部中医药，2005，18（8）：20-21.
[8]	杨彩云，齐进春，薛文勇.前列舒通联合左氧氟沙星治疗慢性细菌性前列腺炎的临床疗效及安全性评价[J].中国临床药理学杂志，2015，31（22）：2187-2189.
[9]	金轶刚，郭晓，汤志灵，等.莫西沙星与左氧氟沙星治疗泌尿系统感染的临床效果对比分析[J].中华医院感染学杂志，2016，26（9）：2105-2107.
[10]	Edwan GMA，Muheilan MM，Atta ONM.Long term efficacy of extracorporeal shock wave therapy[ESWT]for treatment of refractory chronic abacterial prostatitis[J].Annals Med Surg，2017，14（C）：12.
[11]	张存，张建林.喹诺酮类抗生素治疗泌尿系感染细菌耐药性的检测和分析[J].河南医学研究，2017，26（15）：2745-2746.
[13]	蒋东，程瑞，颜勤.银翘红酱解毒汤加减治疗湿热内盛型慢性前列腺炎[J].湖北中医杂志，2016，38（7）：47-48.
[14]	方艳，王保安，赵争胜，等.双石通淋胶囊对大鼠细菌性前列腺炎的影响[J].中成药，2016，38（11）：2472-2475.
[15]	徐青青.热淋清颗粒辅助治疗慢性前列腺炎临床疗效[J].天津药学，2016，28（5）：55-56.
[12]	Vicari LO，Castiglione R，Salemi M，et al.Effect of levofloxacin treatment on semen hyperviscosity inchronic bacterial prostatitis patients[J].Andrologia，2016，48（4）：380-388.